Modeling Principle

The Beagle Alveolar Bone Defect Model is a SCI gold-standard large-animal translational model widely applied in the fields of dental implant restoration, guided bone regeneration (GBR), bone augmentation material development, and bone tissue regeneration mechanism research. Standardized surgical procedures are adopted to construct critical alveolar bone defects in the posterior mandibular region of Beagle dogs, which cannot achieve complete spontaneous osseous healing, accurately simulating clinical pathological scenarios including post-extraction bone resorption, insufficient bone volume before implantation, local jaw bone defect, trauma and postoperative bone deficiency. Beagle dogs exhibit highly homologous jaw cortical/cancellous bone ratio, alveolar bone metabolic rhythm, osteogenic-osteoclastic balance and bone remodeling cycle with humans. Compared with rodent models, Beagles possess sufficient bone thickness, adequate surgical operating space and precisely quantifiable defect dimensions, which can stably recapitulate the complete temporal repair process of clot organization, angiogenesis, osteoid deposition, new bone creeping growth and bone maturation remodeling after human alveolar bone defect formation. With sufficient intervention space, low data dispersion and excellent reproducibility, this model can objectively distinguish the in-vivo osteogenic efficacy and biocompatibility of various bone repair scaffolds, barrier membranes, active factors and stem cell preparations. The experimental paradigm fully meets the standardized experimental specifications of high-impact dental SCI journals, National Natural Science Foundation projects, and postgraduate research proposals and dissertations, serving as the most widely used standardized large-animal model in oral regenerative medicine.

Modeling Success Criteria

Quantitative Imaging Criteria

Immediate postoperative CBCT/Micro-CT verification confirms that bilateral alveolar bone defects are highly symmetrical in size with clear boundaries and continuous and intact bone walls, without intraoperative surgical complications such as bone cracks, fractures and defect deviation; the blank control group has no complete osseous closure at each postoperative time point, and stable bone loss persists in the defect area, strictly conforming to the core biological characteristic of **inability of critical bone defects to achieve spontaneous complete osseous healing**; no pathological bone resorption, extensive osteonecrosis or persistent inflammatory bone destruction is observed in the surgical area of each group. The imaging data have balanced baselines and low inter-group dispersion, which can accurately distinguish the bone regeneration and repair differences of different interventions, confirming successful model establishment.

Histomorphometric Gold-Standard Indexes

The defect area of the blank control group is mainly filled with fibrous connective tissue, and newly formed bone tissue is only limited to the defect edge without mature lamellar bone formation or complete bone bridging structure in the defect center; core histomorphometric indexes: bone volume fraction (BV/TV), new bone area ratio and trabecular number (Tb.N) are significantly lower than those of all intervention groups, while fibrous tissue ratio and inflammatory infiltration degree are significantly higher than those of repair groups; no extensive non-specific inflammation, foreign body giant cell aggregation, persistent chronic inflammation or tissue necrosis is observed in all modeled specimens, with controllable surgical trauma and stable model interference factors, and the data fully meet SCI academic credibility requirements.

Academic Evidence for Model Validity

The core academic validity basis of this model is as follows: standardized critical alveolar bone defects possess stable biological inertia, which can avoid the masking effect of excessive autologous bone repair on experimental results; the inflammatory response after modeling is moderate with stable temporal bone repair rules, which can accurately recapitulate the complete pathophysiological cascade of inflammatory activation, angiogenesis, bone matrix deposition and bone maturation remodeling after clinical alveolar bone defects. This model can objectively and quantitatively evaluate the in vivo repair efficacy of various bone regeneration materials, active factors, stem cell preparations and GBR surgical procedures, serving as the recognized large-animal gold-standard model for translational research of oral bone regeneration and bone augmentation.

Model Advantages

The Beagle Alveolar Bone Defect Model is a mainstream high-impact SCI large-animal model in the research fields of oral bone regeneration, GBR guided bone regeneration and implant bone augmentation materials. Its jaw anatomy, bone metabolic rhythm and osteogenic response mechanism are highly homologous to humans, with significantly better clinical translational value than rodent models. The bilateral intra-animal control design eliminates individual differences to the greatest extent, reduces experimental errors, saves animal sample size and complies with animal ethics. The defect size is accurately controllable with extremely high modeling stability and excellent reproducibility. It can completely recapitulate the full temporal pathophysiological process of inflammation, angiogenesis, bone regeneration and bone maturation after alveolar bone defects. It supports multi-time-point non-invasive in vivo imaging follow-up and multi-dimensional endpoint index detection with a complete closed-loop data chain and high academic credibility. The experimental conclusions have strong translational potential and are easily accepted by authoritative SCI journals in stomatology, biomaterials and regenerative medicine, fully adapting to the research system of National Natural Science Foundation projects, fund application, proposal reports and postgraduate dissertations.

Research Applications

The Beagle Alveolar Bone Defect Model is mainly used to systematically elucidate the core molecular mechanisms of bone defect inflammatory microenvironment regulation, angiogenesis-coupled osteogenesis, bone matrix deposition, trabecular remodeling, and material degradation-bone regeneration temporal matching. It accurately evaluates the in vivo osteogenic efficacy, spatial maintenance capacity, biocompatibility and long-term repair stability of novel bone repair scaffolds, absorbable barrier membranes, bone graft substitutes, sustained drug delivery systems and stem cell composite regenerative materials. It optimizes surgical procedures and intervention strategies for GBR guided bone regeneration and pre-implant bone augmentation, and verifies the preclinical safety and efficacy of oral regenerative biomaterials. It is widely applied in full scientific research scenarios including oral bone tissue engineering mechanism research, novel bone repair material development, preclinical translational experiments of implant restoration, fund project application, research proposal and SCI paper writing.

Beagle alveolar bone defect model，critical bone defect，alveolar bone regeneration，guided bone regeneration，bone augmentation，implant bone defect，dental bone tissue engineering，large-animal translational model